Teva, Bayer Settle Dispute Over Levitra Patents

Law360, New York (November 21, 2011, 7:00 PM EST) -- Two Bayer AG units reached a settlement with Teva Pharmaceuticals USA Inc. over two erectile dysfunction patents, ending the five cases Bayer launched to prevent Teva's bid to make a generic version of its drug Levitra, according to a consent judgment filed Monday.

U.S. District Judge Gregory Sleet signed off on a consent judgment submitted by the parties following a settlement. Under the judgment, the seven claims at issue under U.S. Patent Number 6,362,178 and six claims at issue under U.S. Patent Number 7,696,206 were deemed valid,...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Bayer Schering Pharma AG et al v. Teva Pharmaceuticals USA Inc.


Case Number

1:09-cv-00480

Court

Delaware

Nature of Suit

Patent

Judge

Gregory M. Sleet

Date Filed

July 1, 2009


Case Title

Bayer Schering Pharma AG, et al v. Teva Pharamceuticals USA, Inc.


Case Number

1:10-cv-00299

Court

Delaware

Nature of Suit

Patent

Judge

Gregory M. Sleet

Date Filed

April 13, 2010


Case Title

Bayer Schering Pharma AG et al v. Teva Pharmaceuticals USA Inc. et al


Case Number

1:09-cv-00536

Court

Delaware

Nature of Suit

Patent

Judge

Gregory M. Sleet

Date Filed

July 24, 2009


Case Title

Bayer Schering Pharma AG et al v. Teva Pharmaceuticals USA Inc. et al


Case Number

1:09-cv-00682

Court

Delaware

Nature of Suit

Patent

Judge

Gregory M. Sleet

Date Filed

September 15, 2009


Case Title

Bayer Schering Pharma AG et al v. Teva Pharmaceuticals USA Inc. et al


Case Number

1:10-cv-00616

Court

Delaware

Nature of Suit

Patent

Judge

Gregory M. Sleet

Date Filed

July 20, 2010

Law Firms

Companies

Government Agencies

Patents